| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/23/1990 | EP0368857A1 Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms. |
| 05/23/1990 | EP0195084B1 Method of rectification of human leukocytic interferon |
| 05/23/1990 | DE3838900A1 Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung Pyruvate kinase isoenzyme type m2 (m2 tumor-pk) specific antibodies / process for their production and their use |
| 05/23/1990 | CN1042378A Process for preparing insulin precursor from streptomyces |
| 05/23/1990 | CN1042377A Process for preparing non-glycosylated recombining human il2 in reduced form |
| 05/23/1990 | CA2003695A1 Position-specific insertion vectors and method of using same |
| 05/23/1990 | CA2003383A1 Synthetic dna derived recombinant hiv antigens |
| 05/22/1990 | US4927754 Method for selectively increasing the ratio of single major components of teicoplanin A2 complex |
| 05/22/1990 | CA2003325A1 Process for preparing 63 - carboxyamides of teicoplanin antibiotics |
| 05/22/1990 | CA1269337A1 Human monoclonal antibodies to cytokeratin |
| 05/18/1990 | CA2003273A1 Catalytic and reactive polypeptides and methods for their preparation and use |
| 05/17/1990 | WO1990005194A1 Probe for detection of the fragile x syndrome |
| 05/17/1990 | WO1990005188A1 A genetic construct of which protein-coding dna comprises introns and is designed for protein production in transgenic animals |
| 05/17/1990 | WO1990005185A1 Modified human growth hormone |
| 05/17/1990 | WO1990005184A1 Expression and processing of authentic fgf's in yeast |
| 05/17/1990 | WO1990005183A1 Interleukin-4 receptors |
| 05/17/1990 | WO1990005178A1 Murine hybridoma and diagnostic antibody produced thereby |
| 05/17/1990 | WO1990005177A1 Functional recombinantly prepared synthetic protein polymer |
| 05/17/1990 | WO1990005176A1 Novel bacillus thuringiensis strains |
| 05/17/1990 | WO1990005147A1 Natural killer stimulatory factor |
| 05/17/1990 | WO1990005144A1 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 05/17/1990 | WO1990005142A1 Polypeptides |
| 05/17/1990 | WO1990002802A3 Viral nucleotide sequences |
| 05/17/1990 | CA2003211A1 Monoclonal antibodies |
| 05/17/1990 | CA2002854A1 Recombinant interleukin-2 hybrid proteins |
| 05/16/1990 | EP0368819A1 Expression of the binding subunit of cholera toxin with the aid of foreign promoters and/or leader sequences |
| 05/16/1990 | EP0368711A1 Method for the isolation of glycosylated interleukin-2, and glycosylated interleukin-2 |
| 05/16/1990 | EP0368684A1 Cloning immunoglobulin variable domain sequences. |
| 05/16/1990 | EP0368662A2 Parent cell lines for producing human hybridomas |
| 05/16/1990 | EP0368486A2 Novel inhibitors of platelet binding |
| 05/16/1990 | EP0368466A2 Compositions and methods for the treatment and prevention of gram-negative bacterial infections |
| 05/16/1990 | EP0368367A1 Purification, production and use of tumor necrosis factors |
| 05/16/1990 | EP0368342A2 Process for producing and use of a DNA to increase the productivity in the expression of recombinant genes |
| 05/16/1990 | EP0368224A2 Streptomycete lysozyme gene, method for its isolation and its use |
| 05/16/1990 | EP0368222A1 Anti-fucosylceramide monoclonal antibody |
| 05/16/1990 | EP0368187A2 Insulin derivatives, their use and a pharmaceutical composition containing same |
| 05/16/1990 | EP0368092A1 Ion exchange and separation method |
| 05/16/1990 | EP0217814B1 A process for producing human growth hormone |
| 05/16/1990 | EP0179786B1 High copy number expression vectors |
| 05/16/1990 | CA2003110A1 Monoclonal antibody specifically recognizing n-glycolyl type gm , hydridoma producing the antibody and method for preparing the hybridoma |
| 05/16/1990 | CA2003042A1 Monoclonal antibody recognizing a reg protein |
| 05/15/1990 | US4925796 Method for enhancing glycoprotein stability |
| 05/15/1990 | US4925793 Human immune interferon |
| 05/15/1990 | US4925792 Process for producing proteins correlated with the diphtheric toxin |
| 05/15/1990 | US4925787 Monoclonal anti-idiotypic antibody, method for production thereof, and hybridoma producing said antibody |
| 05/15/1990 | US4925784 Expression and purification of an HTLV-III gag/env gene protein |
| 05/15/1990 | US4925648 Two specific antibodies(or fragments) bound to imaging agents |
| 05/15/1990 | CA1269055A1 Process for producing human epidermal growth factors and analogs thereof |
| 05/14/1990 | CA2002869A1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof |
| 05/14/1990 | CA2002860A1 Antibodies specific for elam-1 and the use thereof |
| 05/14/1990 | CA2002011A1 Normal human growth regulatory receptor for tgf-beta |
| 05/14/1990 | CA2002004A1 Fish crf |
| 05/11/1990 | CA2002609A1 Binding proteins for insulin-like growth factors |
| 05/10/1990 | CA2441636A1 Natural killer stimulatory factor |
| 05/10/1990 | CA2002638A1 Lysozyme gene from streptomycetes, a process for obtaining it, and its use |
| 05/10/1990 | CA2000821A1 Inhibitors of platelet binding |
| 05/09/1990 | EP0367644A1 Nucleotide sequence codings for a protein with urea reactivity |
| 05/09/1990 | EP0367641A2 Lymphokines, DNA sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines |
| 05/09/1990 | EP0367637A1 Eukaryotic multifunctional in vitro system and its uses |
| 05/09/1990 | EP0367605A2 Continuous mammalian cell lines having monocyte/macrophage characteristics and their establishment in vitro |
| 05/09/1990 | EP0367566A1 Interleukin-4 receptors |
| 05/09/1990 | EP0367474A1 Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 05/09/1990 | EP0367447A1 Human epithelial transforming growth factor |
| 05/09/1990 | EP0367163A2 Process for producing an insulin precursor in streptomyces |
| 05/09/1990 | EP0367161A2 Process for selectively hydrolising fusion proteins |
| 05/09/1990 | EP0367063A1 Isolation and cloning of complementary DNA for gene coding of bovine trophoblast protein-1 |
| 05/09/1990 | EP0366816A1 Recombinant platelet-derived growth factor A-chain derived from endothelial cells |
| 05/09/1990 | EP0366662A1 Aminopeptidase for removing n-terminal methionine from proteins and proteins prepared therefrom |
| 05/09/1990 | CN1007907B Purification of recombinant interleukin-2 |
| 05/09/1990 | CN1007906B High pure protein production and use thereof |
| 05/09/1990 | CA2002530A1 Anti-fucosylceramide monoclonal antibody |
| 05/09/1990 | CA2002067A1 Parent cell line for producing human hybridomas |
| 05/08/1990 | US4923967 Interleukins, sulfitolysis |
| 05/08/1990 | US4923807 Arg-Serpin human plasminogen activator inhibitor designated PAI-2 |
| 05/08/1990 | US4923805 Culturing cells capable of glycosylating proteins; gene expression dimerization |
| 05/08/1990 | CA1268900A1 Immunomodulators obtained by hemisynthesis of a bacterial polysaccharide isolated from a mutant strain of klebsiella pneumoniae |
| 05/08/1990 | CA1268722A1 Preparation process of a strain, specifically of yeast, transformed by an expression vector, which can be cultured on a complete culture medium without selection pressure and strain obtained by said process |
| 05/08/1990 | CA1268707A1 Process for the virus-inactivation of immunoglobulin |
| 05/07/1990 | CA2002352A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| 05/07/1990 | CA2002261A1 High molecular weight human angiogenic factors |
| 05/03/1990 | WO1990004788A1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 05/03/1990 | WO1990004642A1 Method for isolating glycosylated interleukine-2 and glycosylated interleukine-2 |
| 05/03/1990 | WO1990004641A1 FILAMENTOUS HEMAGGLUTININ OF $i(B. PERTUSSIS) |
| 05/03/1990 | WO1990004640A1 cDNAs CODING FOR THE η SUBUNIT OF THE HIGH-AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 05/03/1990 | WO1990004637A1 NUCLEOTIDE SEQUENCES EXPRESSING THE ADENYL CYCLASE OF $i(B. ANTHRACIS) |
| 05/03/1990 | WO1990004604A1 Yeast heat shock protein 60 and analogs |
| 05/03/1990 | WO1990004417A1 Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis |
| 05/03/1990 | WO1990004415A1 Anti-idiotypic antibody induction of antitumor response |
| 05/03/1990 | WO1990004413A1 ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED Fc REGIONS |
| 05/03/1990 | WO1990004411A1 Immunogenically active fractions of borrelia burgdorferi |
| 05/03/1990 | WO1990004410A1 A novel family of high affinity, modified antibodies for cancer treatment |
| 05/03/1990 | WO1990004406A1 Drug containing a glycosylated interleukine-2 |
| 05/03/1990 | WO1990000594A3 Recombinant mycobacterial expression vehicles and uses therefor |
| 05/03/1990 | CA2002062A1 Process for the preparation of an insulin precursor in streptomycetes |
| 05/02/1990 | EP0366612A2 Purification of green-plant phytochrome protein and cloning of green-phytochrome genes |
| 05/02/1990 | EP0366550A1 Nucleotide sequences expressing adenylate cyclase from B.anthracis, proteins having the activity of this adenylate cyclase and biological uses |
| 05/02/1990 | EP0366532A1 Medical preparations containing glycosylated interleukin-2 |
| 05/02/1990 | EP0366043A1 Monoclonal antibody |
| 05/02/1990 | EP0365997A2 A novel family of high affinity, modified antibodies for cancer treatment |
| 05/02/1990 | EP0365858A2 Process for reducing the aggregate content of growth hormone-like materials |